Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-10 LAMATTINA JOHN L Director Grant or award +1,004 26,402
2022-06-10 LAMATTINA JOHN L Director Grant or award · Non-Qualified Stock Option (right to buy) +4,340 4,340
2022-06-10 Patel Sunil Director Grant or award +1,004 29,824
2022-06-10 Patel Sunil Director Grant or award · Non-Qualified Stock Option (right to buy) +4,340 4,340
2022-05-13 FOEHR MATTHEW W President and COO Purchase +2,500 $82.76 $207K 173,354
2022-05-10 HIGGINS JOHN L Chief Executive Officer Sale · 0.75% Convertible Senior Notes due 2023 −0 $429,159.38 $0
2022-05-09 HIGGINS JOHN L Chief Executive Officer Option exercise +8,000 $21.92 $175K 348,593
2022-05-09 HIGGINS JOHN L Chief Executive Officer Option exercise · Non-Qualified Stock Option (right to buy) −8,000 57,616
2022-05-05 Berkman Charles S SVP, Gen. Counsel & Secretary Grant or award · Employee Stock Option (right to buy) +20,126 20,126
2022-05-05 Korenberg Matthew E EVP,Finance & Strategy and CFO Grant or award · Employee Stock Option (right to buy) +30,189 30,189
2022-05-05 FOEHR MATTHEW W President and COO Grant or award · Employee Stock Option (right to buy) +34,214 34,214
2022-05-05 HIGGINS JOHN L Chief Executive Officer Grant or award · Employee Stock Option (right to buy) +76,478 76,478
2022-02-28 KOZARICH JOHN W Director Option exercise +7,335 $12.53 $92K 42,117
2022-02-28 KOZARICH JOHN W Director Sale −908 $102.62 $93K 41,209
2022-02-28 KOZARICH JOHN W Director Option exercise · Non-Qualified Stock Option (right to buy) −7,335 0
2022-02-15 Berkman Charles S SVP, Gen. Counsel & Secretary Shares withheld for taxes −368 $123.68 $46K 31,604
2022-02-15 Berkman Charles S SVP, Gen. Counsel & Secretary Shares withheld for taxes −633 $123.68 $78K 30,971
2022-02-15 Berkman Charles S SVP, Gen. Counsel & Secretary Shares withheld for taxes −577 $123.68 $71K 30,394
2022-02-15 FOEHR MATTHEW W President and COO Shares withheld for taxes −1,234 $123.68 $153K 173,166
2022-02-15 FOEHR MATTHEW W President and COO Shares withheld for taxes −1,222 $123.68 $151K 171,944

Page 30 of 43 · 858 trades